Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Full enrollment reached in phase III ACCLAIM chronic heart failure trial

May 9, 2005

BioMarin licenses further 6R-BH4 rights from Daiichi Suntory

May 9, 2005

Predix' 5-HT2B receptor antagonist enters phase I for pulmonary hypertension

May 6, 2005

Measurement of skin cholesterol levels may help estimate the risk of heart disease

May 6, 2005

Therapeutic benefits found for alagebrium in older subjects with systolic hypertension

May 6, 2005

Researchers assess the benefits of VEGF gene therapy in coronary artery disease

May 6, 2005

Kos acquires rights to Biovail products in cardiovascular field

May 6, 2005

Cannabinoid CB2 receptor: potential target for the treatment of atherosclerosis

May 6, 2005

Endovasc discusses Liprostin with the FDA

May 5, 2005

European orphan drug designation for ambrisentan

May 5, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...